Safety and Efficacy of Insulin Detemir in Combination With OAD in Type 2 Diabetes

PHASE3CompletedINTERVENTIONAL
Enrollment

477

Participants

Timeline

Start Date

March 31, 2003

Primary Completion Date

January 31, 2004

Study Completion Date

January 31, 2004

Conditions
DiabetesDiabetes Mellitus, Type 2
Interventions
DRUG

insulin detemir

DRUG

insulin NPH

Trial Locations (62)

1000

Novo Nordisk Investigational Site, Skopje

1346

Novo Nordisk Investigational Site, Gjettum

1357

Novo Nordisk Investigational Site, Bekkestua

2050

Novo Nordisk Investigational Site, Jessheim

2300

Novo Nordisk Investigational Site, København S

2400

Novo Nordisk Investigational Site, Copenhagen

2408

Novo Nordisk Investigational Site, Elverum

2650

Novo Nordisk Investigational Site, Hvidovre

4011

Novo Nordisk Investigational Site, Stavanger

4200

Novo Nordisk Investigational Site, Slagelse

4400

Novo Nordisk Investigational Site, Kalundborg

4500

Novo Nordisk Investigational Site, Huy

4600

Novo Nordisk Investigational Site, Køge

5235

Novo Nordisk Investigational Site, Rådal

6040

Novo Nordisk Investigational Site, Jumet

6060

Novo Nordisk Investigational Site, Gilly

6700

Novo Nordisk Investigational Site, Arlon

8000

Novo Nordisk Investigational Site, Århus C

9800

Novo Nordisk Investigational Site, Hjørring

40107

Novo Nordisk Investigational Site, Dax

58033

Novo Nordisk Investigational Site, Nevers

59322

Novo Nordisk Investigational Site, Valenciennes

69200

Novo Nordisk Investigational Site, Vénissieux

84902

Novo Nordisk Investigational Site, Avignon

89000

Novo Nordisk Investigational Site, Auxerre

91014

Novo Nordisk Investigational Site, Évry

91171

Novo Nordisk Investigational Site, Trenčín

92014

Novo Nordisk Investigational Site, Nanterre

92501

Novo Nordisk Investigational Site, Rueil-Malmaison

117036

Novo Nordisk Investigational Site, Moscow

119435

Novo Nordisk Investigational Site, Moscow

123448

Novo Nordisk Investigational Site, Moscow

127411

Novo Nordisk Investigational Site, Moscow

194354

Novo Nordisk Investigational Site, Saint Petersburg

198013

Novo Nordisk Investigational Site, Saint Petersburg

51 000

Novo Nordisk Investigational Site, Rijeka

10 000

Novo Nordisk Investigational Site, Zagreb

Unknown

Novo Nordisk Investigational Site, Amiens

06250

Novo Nordisk Investigational Site, Mougins

NO-5012

Novo Nordisk Investigational Site, Bergen

NO-2819

Novo Nordisk Investigational Site, Gjøvik

0370

Novo Nordisk Investigational Site, Oslo

88-140

Novo Nordisk Investigational Site, Gniewkowo

31-261

Novo Nordisk Investigational Site, Krakow

90-030

Novo Nordisk Investigational Site, Lodz

20-718

Novo Nordisk Investigational Site, Lublin

96-200

Novo Nordisk Investigational Site, Rawa Mazowiecka

71-455

Novo Nordisk Investigational Site, Szczecin

43-100

Novo Nordisk Investigational Site, Tychy

01-809

Novo Nordisk Investigational Site, Warsaw

01-877

Novo Nordisk Investigational Site, Warsaw

02-097

Novo Nordisk Investigational Site, Warsaw

05-200

Novo Nordisk Investigational Site, Wołomin

41-800

Novo Nordisk Investigational Site, Zabrze

791 82

Novo Nordisk Investigational Site, Falun

467 22

Novo Nordisk Investigational Site, Grästorp

291 85

Novo Nordisk Investigational Site, Kristianstad

581 85

Novo Nordisk Investigational Site, Linköping

221 85

Novo Nordisk Investigational Site, Lund

223 70

Novo Nordisk Investigational Site, Lund

231 85

Novo Nordisk Investigational Site, Trelleborg

901 85

Novo Nordisk Investigational Site, Umeå

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Novo Nordisk A/S

INDUSTRY